Sponge hemostatic collagenic (Hemostatic collagen sponge)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceBoric acid + Nitrofural + [Collagen]Boric acid + Nitrofural + [Collagen]
Dosage form: & nbspsponge
Composition:

For 1 g of the drug:

collagen, substance-solution 2% 49 g (0.98 g of dry collagen), nitrofural (furacilin) ​​0.0075 g, boric acid 0.0125 g.

Description:

Plates of yellow color with a specific smell of acetic acid, with a relief surface, with a porous structure, a thickness of 5 to 9 mm.

Pharmacotherapeutic group:Hemostatic agent for topical application
ATX: & nbsp

B.02.B.C.07   Collagen

Pharmacodynamics:

The drug has a local hemostatic and antiseptic effect, stimulates the regeneration of tissues. The sponge left in the wound or cavity is completely absorbed. Upon contact of the haemostatic collagen sponge with the bleeding surface, adhesion and aggregation of platelets occurs, which leads to a rapid arrest of capillary-parenchymal bleeding. Collagen undergoes biodegradation - a gradual resorption in the body for 3-6 weeks, which allows to leave the material at the site of application without subsequent removal. The products of biodegradation (lysis) of collagen stimulate the processes of wound repair, speeding up the healing of wounds. Contained in a sponge boric acid and nitrofural have antiseptic and antimicrobial effect.

Indications:

As a haemostatic agent for capillary and parenchymal hemorrhages from:

- sinuses of the dura mater;

- the osteo-cerebral canal;

- alveolar socket after tooth extraction;

- Parenchymal organs (in particular, after resection of the liver);

- the bed of the gallbladder after holicystectomy.

Contraindications:

- Increased individual sensitivity to the components of the drug;

- intolerance to nitrofuran drugs (nitrofural, furazidine, nitrofurantoin, furazolidone, nifuratel, nifuroxazide);

- Arterial bleeding;

- purulent wounds, pyoderma.

Pregnancy and lactation:

Contraindications for use during pregnancy and lactation are not revealed.

Dosing and Administration:

The sponge is removed from the package immediately before use, observing the rules of asepsis. Apply to a bleeding place and press against it for 1-2 minutes or tightly swab the bleeding surface, followed by bandaging. After soaking in the blood, the sponge fits snugly against the bleeding surface.To close the damaged parts of the parenchymal organs (liver) or the bed of the gallbladder after cholecystectomy, the sponge is placed in the damaged cavity. If the bleeding does not stop, you can put a second layer of the sponge. After stopping bleeding, the sponge is fixed with a U-shaped seam. The further conduct of the operation is carried out according to the accepted methods. To stop bleeding from the vascular seam, the bleeding place is covered with a sponge. After stopping bleeding, the sponge is not removed, since it subsequently resolves completely. The size and amount of the sponge used is selected in accordance with the size of the bleeding surface or the volume of the cavity.

Side effects:ATAllergic reactions are possible.
Overdose:

Cases of overdose are not described.

Interaction:

Hemostatic action of the sponge is enhanced if it is additionally moistened with a solution of thrombin.

Form release / dosage:Sponge.
Packaging:

Sponge size (50 ± 5) x (50 ± 5) mm for 1 pc. and (90 ± 10) x (90 ± 10) mm for 1 pc. are sealed in two-layer bags of polyethylene film, or in containers made of polyvinylchloride film and aluminum foil with a heat-sealable coating, or from films: polymer, "Poliform", ""Plastiplen" and laminated paper, or only from films: polymer, "Poliform", "Plastiplen".

Sponge diameter (11 ± 1) mm for 10, 20, 30 pieces. Packed in a contour mesh box made of PVC film and aluminum foil with a heat-sealable coating.

A contoured cellular package or a two-layer bag of polyethylene film or a container together with an instruction for use is placed in a cardboard package.

For treatment and prevention institutions, two-layer bags of polyethylene film or containers of 10, 20, 30 pcs. together with instructions for use in an amount equal to the number of primary packages, a carton box is placed in a group package.

Storage conditions:In a dry, dark place at a temperature of 10 to 30 ° C. Keep out of the reach of children.
Shelf life:

5 years.

Do not use at the end of the expiration date printed on the package.

Terms of leave from pharmacies:Without recipe
Registration number:P N001656 / 01
Date of registration:08.08.2008
Expiration Date:Unlimited
The owner of the registration certificate:BELKOZIN - LUZHSKY FACTORY, OJSC BELKOZIN - LUZHSKY FACTORY, OJSC Russia
Manufacturer: & nbsp
Information update date: & nbsp11.05.2017
Illustrated instructions
    Instructions
    Up